People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...

NARCAN ® Nasal Spray is easy to administer and works by ... taking the wrong dose of a prescribed pain pill after a surgery, or a student who takes a pill from a friend to help them study ...

But there’s far more to his story: He received a life-altering brain tumor diagnosis at just 24 years old, and post-surgery pain ... like NARCAN ® Nasal Spray, to help save a life,” Clark ...

Actual results may differ materially from these preliminary unaudited results following the completion of year-end closing procedures, final adjustments ... of neffy in the same nostril with a new ...

That procedure is so invasive that it's just not ... Health News // 4 days ago FDA approves Spravato, first monotherapy nasal spray to treat depression Jan. 21 (UPI) -- The Food and Drug ...